01023cam--2200361---450 99000610572020331620200421183517.088-86441-05-3000610572USA01000610572(ALEPH)000610572USA0100061057220151214d1994----km-y0itay5003----baitaIT||||||||001yy<<I>> poemettiStefano Finiguerri detto il Zaa cura di Antonio LanzaRomaZauli arti grafiche1994195 p.17 cm<<I>> balasci32001<<I>> balasci3851.2FINIGUERRI,Stefano318241LANZA,Antonio<1949- >ITsalbcISBD990006105720203316XV.3. 2194208431 L.M.XV.3.00278545BKPAPGIUSY9020151214USA011602GIUSY9020151214USA011604Poemetti1383779UNISA01135nam2 2200289 i 450 VAN004663220090417120000.088-87920-00-120060626d2000 |0itac50 baitaIT|||| |||||ˆ1: L'‰angosciaJean Laplancheed. it. a cura di Alberto LuchettiBari : La bibliotecac2000389 p. : ill. ; 21 cmTrad. di Alberto Luchetti.001VAN00466432001 ˆIl ‰progetto psicoanalitico210 BariLa biblioteca.1001VAN00466212001 ProblematicheJean Laplanche210 BariLa biblioteca215 v.21 cm.1BariVANL000009RomaVANL000360LaplancheJeanVANV016617160143ITSOL20220506RICABIBLIOTECA DEL DIPARTIMENTO DI PSICOLOGIAIT-CE0119VAN16VAN0046632BIBLIOTECA DEL DIPARTIMENTO DI PSICOLOGIA16CONS 3257 16VS 775 20060626 Angoscia749542UNICAMPANIA01723nam0 22004091i 450 UON0041595820231205104800.72620130110d1981 |0itac50 baitaIT|||| 1||||MetaforaG. BonsiepeJ. Deridda...[et al.]a cura di Giuseppe ConteMilanoFeltrinelli1981 250 p.21 cm.001UON001715062001 SC /10Readings 210 MilanoFeltrinelli21METAFORA NELLA LETTERATURAUONC076564FIITMilanoUONL000005410Linguistica21BONSIEPEG.UONV212434709702DERIDDAJ.UONV212443709704EMPSONWilliamUONV128737131636GenetteGérardUONV119150384264HESSEM.B.UONV212445709705JakobsonRomanUONV031794126074OLBRECTHTS-TYTECAL.UONV212446709703PERELMANChaimUONV061836347052RICHARDSI.A.UONV172971559856RICOEURPaulUONV060451437317SARDUYSeveroUONV133069163504CONTEGiuseppeUONV101295FeltrinelliUONV246160650ITSOL20250613RICAUON00415958SIBA - SISTEMA BIBLIOTECARIO DI ATENEOSI Fil.R BB 005 SI LO 27275 7 005 BuonoSIBA - SISTEMA BIBLIOTECARIO DI ATENEOSI ITA II 1189 SI LO 16077 5 1189 BuonoMetafora1338453UNIOR04097nam 2201081z- 450 991055749350332120210501(CKB)5400000000042896(oapen)https://directory.doabooks.org/handle/20.500.12854/68560(oapen)doab68560(EXLCZ)99540000000004289620202105d2021 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierFate of Free, "Masked" and Conjugated/Modified forms of MycotoxinsBasel, SwitzerlandMDPI - Multidisciplinary Digital Publishing Institute20211 online resource (162 p.)3-0365-0158-4 3-0365-0159-2 International trade is highly affected by mycotoxin contaminations, which result in an annual 5% to 10% loss of global crop production. In the last decade, the mycotoxin scenario has been complicated by the progressive understanding-alongside emerging mycotoxins-of the parallel presence of modified (masked and conjugated) forms, in addition to the previously free known ones. The present Toxins Special Issue presents original research papers and reviews that deal with the fates of all these forms of mycotoxins with respect to aspects that cover traditional and industrial food processing, yearly grain campaign peculiar conditions and management, novel analytical solutions, consumer exposure, and biomarker-assessment directions. It gives a taste of an exciting scientific field that has several implications for our daily life because (i) it covers our diet practically and from every point of view, (ii) it intersects with our culinary uses and customs, but also industrial production processes, and (iii) it involves a careful evaluation of costs and benefits and a constant and continuous improvement of mycotoxin mitigation strategies.Research & information: generalbicssc14(R)-ochratoxin A2'R-ochratoxin Aacrylamideadolescentsaflatoxinsalkalinebakery food processingbeerbiomonitoringbiscuitsbranchildrenChinese steamed breadcoffeeconversioncookingdecontaminationdegradationdeoxynivalenoldeoxynivalenol-3-glucosidedesign of experimentdesign of experimentsdetoxificationdietary exposureemerging mycotoxinsfluorescence polarization immunoassayfood processingfumonisinsFusariumFusarium toxinsHT-2 glucosideHT-2 toxinhydrolyzed fumonisinsLC-MS/MSmaizemaltmasamasked mycotoxinsmass spectrometrymatrix-associated mycotoxinsmillingmodified mycotoxinsmultiple mitigation strategiesmycotoxinmycotoxinsn/aOchratoxin Apregnant womenprocessingrisk assessmentroastingscreening methodsemolinaSerbiaT-2 glucosideT-2 toxinthermal degradationtortillastrichothecenesvalidation studyvegetarianswheatResearch & information: generalSuman Micheleedt1314819Suman MicheleothBOOK9910557493503321Fate of Free, “Masked” and Conjugated3032007UNINA04186nam 2200937z- 450 991057688530332120220621(CKB)5720000000008321(oapen)https://directory.doabooks.org/handle/20.500.12854/84441(oapen)doab84441(EXLCZ)99572000000000832120202206d2022 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierCoronaviruses Research in BRICS CountriesBaselMDPI - Multidisciplinary Digital Publishing Institute20221 online resource (168 p.)3-0365-4028-8 3-0365-4027-X SARS-CoV-2 has infected more than 105 million people worldwide. During this pandemic, researchers and clinicians have been working to understand the molecular mechanisms that underpin viral pathogenesis by studying viral-host interactions. Now, with the global rollout of various COVID-19 vaccines-based on the neutralization of the spike protein using different technologies-viral immunology and cell-based immunity are being investigated. Researchers are also studying how various SARS-CoV-2 genetic mutations will impact the efficacy of these COVID-19 vaccines. At the same time, various antiviral drugs have been identified or repurposed that have potential as anti-SARS-CoV-2 treatments. BRICS (Brazil, Russia, India, China, and South Africa) is the acronym used to associate five major emerging national economies. The BRICS countries are known for their significant influence on regional affairs, including being leaders in scientific and clinical research and innovation. This Special Issue includes researchers from BRICS countries, in particular South Africa, involved in the study of SARS-CoV-2 and COVID-19. Original articles, as well as new perspectives or reviews on the matter, were welcomed. Research in the fields of vaccine studies, pathogenesis, genetic mutations, viral immunology, and antiviral drugs were especially encouraged.Epidemiology and Medical statisticsbicsscMedicine and Nursingbicsscaerosolbioinformatics and vaccine developmentBrazilbreakthroughconvalescent plasmacoronavirus disease 2019 (COVID-19)corticosteroidsCOVID-19COVID-19 and nanotechnologyCOVID-19 testingDelta and Delta plus variantdental aerosol-generating proceduresdetectiondiabetesdifferent settingsE484Kepitope coverageextra-oral suctiongenomic epidemiologyhigh-volume evacuationhospital mortalityhumoral responseimmunoassayIndiaintervention strategiesintubationlow-volume saliva ejectormodelsnanomedicine in South Africananotechnologyneutralizing antibody (NAb)NSWprotein microarrayquantitative antibody bindingreverse zoonosisSARS-CoV-2SARS-CoV-2 antibodiesSARS-CoV-2 nucleocapsid proteinsevere acute respiratory syndrome coronavirus (SARS-CoV-2)splattertreatmentvaccinevaccine development in South Africavariant of InterestVRDLwildlifeEpidemiology and Medical statisticsMedicine and NursingFielding Burtram Cedt1291013Schäfer GeorgiaedtFielding Burtram CothSchäfer GeorgiaothBOOK9910576885303321Coronaviruses Research in BRICS Countries3021755UNINA